NCLT Rejects Insolvency Petition Against Gaudium IVF
NCLT New Delhi rejected an insolvency petition filed by Ramaa Capital against Gaudium IVF and Women Health Limited on May 15, 2026. The company received the order on May 22, 2026, confirming no impact on its financial or operational activities.
*this image is generated using AI for illustrative purposes only.
gaudium ivf & women health has announced that the National Company Law Tribunal (NCLT), New Delhi Bench, has rejected an insolvency petition filed against it. The order was passed by the Hon'ble NCLT on May 15, 2026, in the matter of M/s. Ramaa Capital versus the company.
The petition, bearing number C.P. (IB)/243/ND/2026, was filed under Section 9 of the Insolvency and Bankruptcy Code, 2016, by the operational creditor. The company received a copy of the said order on May 22, 2026.
Details of the Order
The disclosure was made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The key details regarding the regulatory order are outlined below:
| Sr. No. | Particulars | Description |
|---|---|---|
| 1. | Name of the authority | Hon'ble National Company Law Tribunal (NCLT) |
| 2. | Nature and details of the action(s) taken or order(s) passed | The Hon'ble NCLT, New Delhi Bench, vide order dated May 15, 2026, has rejected the Petition of the Operational Creditor. |
| 3. | Date of receipt of direction or order | May 22, 2026 |
| 4. | Details of the violation(s)/ contravention(s) committed or alleged to be committed | Not Applicable |
| 5. | Impact on financial, operation or other activities of the listed entity | There is no impact on financial, operation or other activities of the Company. |
Impact Assessment
The company has confirmed that the rejection of the petition has no quantifiable monetary impact on its financial, operational, or other activities. The information has been submitted to the exchanges and is also available on the company's website.
Historical Stock Returns for Gaudium IVF & Women Health
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.43% | +5.07% | +11.46% | +43.37% | +43.37% | +43.37% |
Will M/s. Ramaa Capital appeal the NCLT rejection in the National Company Law Appellate Tribunal (NCLAT), and what would be the timeline and implications for Gaudium IVF if such an appeal is filed?
How might this resolved insolvency threat affect Gaudium IVF's ability to secure future financing, attract investors, or pursue expansion plans in the competitive fertility healthcare market?
Are there any other pending legal disputes or creditor claims against Gaudium IVF that could pose similar insolvency risks in the near future?
18
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
